Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis

BACKGROUND: Biomarkers represent a potential tool to identify individuals at risk for anthracycline-induced cardiotoxicity (AICT) prior to symptom onset or left ventricular dysfunction. METHODS: This study examined the levels of cardiac and noncardiac biomarkers before, after the last dose of, and 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Matthew, Kim, Min Jung, Dimauro, Sharon, Tannenbaum, Susan, Graham, Garth, Liang, Bruce T., Kim, Agnes S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133897/
https://www.ncbi.nlm.nih.gov/pubmed/37106424
http://dx.doi.org/10.1186/s40959-023-00174-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133897/
https://www.ncbi.nlm.nih.gov/pubmed/37106424
http://dx.doi.org/10.1186/s40959-023-00174-1

Ejemplares similares